The relative effect of self-management practices on glycaemic control in type 2 diabetic patients in Mexico

Chronic Illness

Volumn 2, Issue 2, 2006, Pages 77-85

  Garcia De Alba Garcia, Javier E ^a,b   Dallo, Florence J ^c   Salcedo Rocha, Ana L ^a,b   Rodriguez, Cecilia Colunga ^a   Perez, Noe ^d   Baer, Roberta D ^e   Weller, Susan C ^d  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^c UNIVERSITY OF MICHIGAN   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Diabetes self management; Glycaemic control; Mexico; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; PROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIABETES CONTROL; DIABETIC DIET; EXERCISE; FAMILY MEDICINE; FEMALE; GENERAL PRACTICE; GLYCEMIC CONTROL; HEALTH BEHAVIOR; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MANAGEMENT; MEXICO; NON INSULIN DEPENDENT DIABETES MELLITUS; THERAPY EFFECT; TREATMENT OUTCOME;

ADULT; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; LOGISTIC MODELS; MEXICO; ODDS RATIO; SELF CARE;

EID: 33745736963     PISSN: 17423953     EISSN: 17459206     Source Type: Journal    
DOI: 10.1179/174592006X110950     Document Type: Article

References (36)

1. Gonzalez Villalpando ME, Gonzalez VC, Arredondo PB, Stern MP. Diabetic retinopathy in Mexico. Prevalence and clinical characteristics. Arch Med Res 1994; 25: 355-60.
2. Gonzalez VC, Stern MP, Arredondo PB, et al. Nephropathy in low income diabetics: the Mexico City Diabetes Study. Arch Med Res 1996; 27: 367-72.
3. Paisey RB, Arredondo G, Villalobos A, Lozano O, Guevara L, Kelly S. Association of differing dietary, metabolic, and clinical risk factors with macrovascular complications of diabetes: a prevalence study of 503 Mexican type II diabetic subjects. I. Diabetes Care 1984; 7: 421-7.
4. Gu K., Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993. Diabetes Care 1998; 21: 1138-45.
5. Direccion General de Informacion y Evaluacion del Desempeno, Secretaria de Salud. Estadisticas de mortalidad en Mexico: muertas registradas en el ano 2001. Salud Pùblica de Mèxico 2003; 44: 565-76.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
7. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-65.
8. Aguilar-Salinas CA, Monroy OV, Gómez-Pérez FJ, et al. Characteristics of patients with type 2 diabetes in Mexico: results from a large population-based nationwide survey. Diabetes Care 2003; 26: 2021-6.
9. Lerman I, Lozano L, Villa AR, et al. Psychosocial factors associated with poor diabetes self-management in a specialized center in Mexico City. Biomed Pharmacother 2004; 58: 566-70.
10. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
11. Cowie CC, Rust KF, Byrd-Holt D, et al. Prevalence of diabetes and impaired fasting glucose in adults - United States, 1999-2000. MMWR 2003; 52: 833-7.
12. Rull Rodrigo JA. El impacto de la diabetes mellitus en Mèxico. In: Garcia Viveros M, Silva Garcìa J, Salas Mercado K, eds. La Salud en Mèxico Ante El Pròximo Mileno. Mexico City: Miguel Angel Porrua, 2000, 95-7.
13. Blaum CS, Velez L, Hiss RG, Halter JB. Characteristics related to poor glycemic control in NIDDM patients in community practice. Diabetes Care 1997; 20: 7-11.
14. Hu D, Henderson JA, Welty TK, et al. Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study. Diabetes Care 1999; 22: 1802-7.
15. Bruce DG, Davis WA, Davis TM. Glycemic control in older subjects with type 2 diabetes mellitus in the Fremantle Diabetes Study. J Am Geriatr Soc 2000; 48: 1449-53.
16. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 1999; 22: 403-8.
17. Bruno G, Cavallo-Perin P, Bargero G, Borra M, D'Errico N, Pagano G. Glycaemic control and cardiovascular risk factors in type 2 diabetes: a population-based study. Diabetes Med 1998; 15: 304-5.
18. American Diabetes Association. Clinical practice recommendations 2002. Diabetes Care 2002; 25 Suppl. 1: S1-S147.
19. Zung WK, Durham MD. A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63-70.
20. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation 1993; 88: 2460-70.
21. SAS Institute. SAS procedures guide (9.0). Cary, NC: SAS Institute, 2003.
22. Stokes ME, Davis CS, Koch GG. Categorical data analysis using the SAS system, 2nd edn. Cary, NC: SAS Institute, 2001.
23. Rajala U, Keinänen-Kiukaanniemi S, Kevelä S.-L. Non-insulin-dependent diabetes mellitus and depression in a middle-aged Finnish population. Psychiatry Psychiatr Epidemiol 1997; 32: 363-7.
24. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Pubication 1-3670. Bethesda, MD: NIH, NHL BI, 2001.
25. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999; 281: 2005-12.
26. Rull JA, Aguilar-Salinas, Rojas R, Rios-Torres JM, Gomez-Perez FJ, Olaiz G. Epidemiology of type 2 diabetes in Mexico. Arch Med Res 2005; 36: 188-96.
27. Hernàndez-Ronquillo L, Tèllez-Zenteno JF, Garduño-Espinosa J, Gonzàles-Acevez E. Factors associated with therapy non-compliance in type-2 diabetes patients. Salud Pùblica de Mèxico 2003; 45: 1-7.
28. Harris MI. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care 2001; 24: 979-82.
29. Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complication of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-12.
30. Deakin T, McShane CE, Cade JE, Williams RDRR. Group based training for self-management strategies in people with type 2 diabetes mellitus (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford: Wiley, 2005, 1-72.
31. Coster S, Gullifor MC, Seed PT, Powrie JK, Swaminathan R. Self-monitoring in type 2 diabetes mellitus: a meta-analysis. Diabetic Med 2000; 17: 755-61.
32. Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes Registry. Am J Med 2001; 111: 1-9.
33. Wing RR, Marcus MD, Salata R, Epstein LH, Miaskiewicz S, Blair EH. Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med 1991; 151: 1334-40.
34. Zapotoczky H, Semlitsch B, Herzog G, et al. A controlled study of weight reduction in type 2 diabetics treated by two reinforcers. Int J Behavioral Med 2001; 8: 42-9.
35. Brown SA, Upchurch S, Anding R, Winter M, Ramirez G. Promoting weight loss in type II diabetes. Diabetes Care 1996; 19: 613-24.
36. Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 2001; 286: 1218-27.